Annual Report - FIP

More documents

Recommendations

Info

8 Annual Report 200 7 8 Congress Travel Grant Award Reports Report on participation at 67th International Congress of FIP, Beijing, China 2007 By Hagar Ibrahim, Alexandria, Egypt 2007 FIP Congress Travel Grant Awardee My name is Hagar Ibrahim. I work as a lecturer assistant at the Faculty of Pharmacy, University of Alexandria, Egypt. I was one of the recipients of FIP travel grants for attending the 67 th International Congress of FIP at Beijing, China 2007. I was really impressed by the outstanding scientific climate and the friendly environment during the congress days. The sessions were given by well-recognized speakers. Some of these sessions were relevant to my area of specialization, for instance, the talk on the regulations and the specifications for in vitro testing of novel dosage forms by Dr Cynthia Brown, a research-based talk on lipid-based formulations for enhancing the solubility of poorly soluble drugs by Dr Chris Porter, Dr Pauletti's talk on the use of nanocarriers for gene delivery, "industrial nanomanufacturing of drug delivery systems" by Dr Kawashima, the talk by Dr Zhang Qiang from University of Beijing on nanoparticulate formulations and others. This was of outmost importance in terms of valuable information, latest pharmaceutical trends through the presentations and through answering questions, asked by me or by other participants, which they highly encouraged and responded to. The congress was also a chance for direct contact with these great scientists, to benefit from their experience and meet other young researchers from all around the globe and explore some ideas with them. The congress has also allowed me to make good friends like Dr Sandra Klein from University of Frankfurt, Germany and Dr Cheng Tong working at Pfizer at the USA. Besides this, I presented part of my work completed during my master program as an oral presentation in the industrial pharmacy section of the congress. The presentation was entitled "Verapamil hydrochloride microspheres for potential topical applications" and it was acknowledged by the present professors, scholars and colleagues. This was a great experience for me knowing that this was the first time for me to give a podium presentation in a conference. Moreover, there was also a room to attend sessions of other sections especially the session on "The use of informatics to improve medication safety" which included very interesting and interactive talks. Finally, attending the congress has achieved my objectives in terms of valuable and updated scientific information, building relationships with others and enhancing my personal development. The experience gained through attending such a successful congress will positively affect my research work aiming for influencing pharmaceutical industry at my home country, Egypt. This will also allow me to take more active role in my society through passing the experience and knowledge I got to my colleagues
and to the undergraduate students, encouraging them to attend international congresses such as the FIP. Such a great experience wouldn't have become possible if not for the travel grant from the FIP foundation. These grants are of outmost importance for young researchers like me in the developing countries. For that, I would like to thank the FIP for giving me the chance to present my work and enhance my skills and knowledge, with FIP financial assistance, at the 67 th International Congress of FIP. Report on participation at 67th International Congress of FIP, Beijing, China 2007 By Dr. Subhash C. Mandal, M.Pharm., Ph.D (Pharm.), India 2007 FIP Congress Travel Grant Awardee It is my proud privilege to report that I have attended the World Congress of Pharmacy and Pharmaceutical Sciences 67 th International Congress of FIP held at Beijing, China during 31 st August - 6 th September 2007 and presented a paper. This was possible due to the Travel Grant offered to me by the FIP Foundation for Education and Research. I have presented a paper in the poster session of Pharmacoepidemiology / Pharmacoeconomics entitled "Study on trends of drug use by private practitioners in a town in India and its impact on treatment cost" which was appreciated by the participants. Pharmacists are essential participants of the health care team and the field of drugs and pharmaceuticals who can work in this area to reach medicines of proper quality, proper amount, at proper time for different clinical conditions to the general mass. My presentation is a humble contribution to the global research to reach medicines to the underprivileged. An exhibition was organized during 3 rd - 6 th September 2007. Several exhibitors participated from different countries around the globe. It was revealed that China has an integrated system of health care system, which was reported by the exhibitors of Chinese manufacturers of both modern and traditional systems of medicine. Some exhibitors displayed their products like-Transdermal Patch, which involves highest modern technology, whereas some have displayed products of traditional system of medicines. A trend is interesting, which is that they are continuously modernizing their TCM based on scientific approach. It was worthy to visit that State Food & Drugs Administration (SFDA) of People's Republic of China exhibited mobile Laboratories having modern facilities including HPLC, IR spectrophotometer. They reported that they go to remote places of the country and test drug samples on the spot to check counterfeit drugs. Three hundred and fifty three Mobile Labs were deployed by SFDA in 28 provinces during February 2006 to August 2007. This measure reflected results in checking counterfeit medicines and is extremely appreciable. Outcome: 1. This occasion gave an opportunity to know a large number of facets of the pharmacy profession. I came to know the actual status of Pharmacy Practice throughout the globe, which has helped me to realize how to take suitable measures for the development of community pharmacy of our country in proper direction. 9 Annual Report 200 7 8
Page 1: Annual Report 200 7 8
Page 4 and 5: 2 Annual Report 200 7 8 Contents Ye
Page 6 and 7: 4 Annual Report 200 7 8 Americas: M
Page 8 and 9: 6 Annual Report 200 7 8 decision ma
Page 12 and 13: 10 Annual Report 200 7 8 2. During
Page 14 and 15: 12 200 Annual Report 7 8 I shared m
Page 16 and 17: 14 200 Annual Report 7 8 ? I am ext
Page 18 and 19: 16 200 Annual Report 7 8 I look for
Page 20 and 21: 18 200 Annual Report 7 8 ? what kin
Page 22 and 23: 20 Annual Report 200 7 8 Foundation
Page 24 and 25: 22 Annual Report 200 7 8 INCOME Sta
Page 26: 24 Annual Report 200 7 8

Annual Report - FIP

Create successful ePaper yourself

Delete template?

Save as template?